A study suggests that omega-3 fatty acids do not benefit patients with relapsing-remitting multiple sclerosis. The fatty acids were thought to be an anti-inflammatory and have neuro-protective benefits in the disease. The study appeared online in the Archives of Neurology. Harry Rice of the Global Organization for EPA and DHA Omega-3 said conclusions cannot be drawn from the study. "The reality is that results from an underpowered study cannot be interpreted with any certainty," he said.

Related Summaries